Dose: 4 mg
Single Dose: 4 (4)
Frequency: 12 hourly
Route: PO
Instructions: The full therapeutic dose can be given upon starting treatment. After 3 - 4 weeks, this dose can be increased to 10 mg/day in case of incomplete clinical response.

.

Reboxetine is contraindicated in conditions like Pregnancy,Breast feeding.

The symptomatic adverse reactions produced by Reboxetine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Vertigo, Tachycardia, Constipation, Insomnia, Sweating, Dry mouth, Dysuria, Impotence, Postural hypotension, Hypokalemia, Paresthesias, Urinary RetentionX, Urinary retention.

Reboxetine is primarily indicated in conditions like Depressive illness.

No data regarding the interactions of Reboxetine was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Reboxetine should be used with caution in patients with severe renal impairment, hepatic impairment, history of cardiovascular disease and epilepsy, bipolar disorders, urinary retension, prostatic hypertrophy, glaucoma.